Publication:
Neoadjuvant chronomodulated capecitabine with radiotherapy in rectal cancer: a phase II brunch regimen study

Placeholder

Organizational Units

Program

Authors

Akgun, Zuleyha
Saglam, Sezer
Yucel, Serap
Gural, Zeynep
Balik, Emre
Cipe, Gokhan
Yildiz, ŞEYMA
Kilickap, Sadettin
Okyar, Alper
Kaytan-Saglam, Esra

Advisor

Language

Publisher

Journal Title

Journal ISSN

Volume Title

Abstract

The aim of this study was to evaluate efficacy and safety of chronomodulated capecitabine administered according to a specific time schedule (Brunch Regimen: Breakfast and Lunch) as a part of neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer.

Description

Source:

Keywords:

Keywords

Citation

Akgun Z., Saglam S., Yucel S., Gural Z., Balik E., Cipe G., Yildiz Ş., Kilickap S., Okyar A., Kaytan-Saglam E., -Neoadjuvant chronomodulated capecitabine with radiotherapy in rectal cancer: a phase II brunch regimen study-, CANCER CHEMOTHERAPY AND PHARMACOLOGY, cilt.74, ss.751-756, 2014

Endorsement

Review

Supplemented By

Referenced By

0

Views

0

Downloads

View PlumX Details


Sustainable Development Goals

Thumbnail Image
Goal